Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AtmanCo Inc Closes $592,835 Final Tranche-Canada Stockwatch News


Thursday, 15 Nov 2012 11:37am EST 

Canada Stockwatch News reported that AtmanCo Inc., previously known as Biotonix (2010) Inc., has closed the second and final tranche of its brokered public offering by way of its prospectus. Under the terms of the second closing, the Company issued 1,976,115 units at a price of 30 cents per unit, raising gross proceeds of $592,835 and completing the public financing for a total of $2,122,804. Each unit comprises one share and one-half of one warrant, each full warrant entitling its holder to acquire one share of the Company at a price of 60 cents on or before November 14, 2014. The units were sold pursuant to an agency agreement with Industrial Alliance Securities Inc. AtmanCo also announces that it will attempt to raise the additional $377,196 that could have been raised through public financing through private placement. The private placement will be non-brokered and will aim to sell a maximum of 1,257,320 units at a price of 30 cents per unit. The maximum raised under the terms of the public and private financing will thus be $2.5-million. The units issued under private placement will follow the same terms as the units issued through public financing. The company expects to close the private placement before the end of November. The company's shares will resume trading after the TSX Venture Exchange issues its final bulletin in respect of the reverse takeover of the company, and the above-mentioned public and private financing, 

Company Quote

0.18
0.03 +20.00%
9 Jul 2014